ARDX, aside from issues noted by iandy in prior post, just saying that if the drug launch was not in the models at the time those burn estimates were put out, they are going to be way off, and a financing to take advantage of this pop could be imminent. I'll shut up now, I haven't followed ARDX in over a year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.